Form 483

Kao USA Inc. Form 483, 2017-04-12

FDA issued a Form 483 to Kao USA Inc. on 2017-04-12 with 10 public-safe observations.

483· Form 483 issuedHuman Drugs10 observations

Kao USA Inc. · Cincinnati, United States · Issued April 12, 2017

Overview

  • 10 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Apr 2017
21 CFR 211.160(b)(4)

Written calibration procedures

Cited by Lindsey M Schwierjohann, Mary B Sheets

12 Apr 2017
21 CFR 211.160(b)(4)

Written calibration procedures

Cited by Lindsey M Schwierjohann, Mary B Sheets

12 Apr 2017
21 CFR 211.166(a)

Written program not followed

Cited by Lindsey M Schwierjohann, Mary B Sheets

12 Apr 2017
21 CFR 211.166(a)

Written program not followed

Cited by Lindsey M Schwierjohann, Mary B Sheets

12 Apr 2017
21 CFR 211.194(e)

Stability testing records not included

Cited by Lindsey M Schwierjohann, Mary B Sheets

Inspected site

KUKao USA Inc.Cincinnati, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations2x
21 CFR 211.166(a)Cited across public-safe Form 483 observations2x
21 CFR 211.194(e)Cited across public-safe Form 483 observations2x
21 CFR 211.22(d)Cited across public-safe Form 483 observations2x
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 10 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere